Highbridge Capital Management’s Phibro Animal Health PAHC Stock Holding History

Highbridge Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,398	Closed	-$214K	–	1227
2018 Q1	$214K	Buy	+5,398	New	+$200K	﹤0.01%	1034
2017 Q2	–	Sell	-8,992	Closed	-$252K	–	1508
2017 Q1	$252K	Buy	+8,992	New	+$254K	﹤0.01%	1231
2016 Q3	–	Sell	-12,429	Closed	-$232K	–	1600
2016 Q2	$232K	Buy	+12,429	New	+$259K	﹤0.01%	1179

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return

Highbridge Capital Management's PAHC Position: Q2 2018 in Review

Highbridge Capital Management sold out of Phibro Animal Health (PAHC) in Q2 2018, closing a stake of 5,398 shares — an estimated $214K sold.

Highbridge Capital Management first reported a position in PAHC in Q2 2016 and held it in 3 quarters. The position peaked at $252K in Q1 2017. 174 funds tracked by Wall St. Rank hold PAHC as of Q2 2018.

Highbridge Capital Management reported no remaining Phibro Animal Health position as of Q2 2018 after selling out during the quarter.
Highbridge Capital Management sold 5,398 Phibro Animal Health shares in Q2 2018, an estimated $214K.
Highbridge Capital Management first reported a position in Phibro Animal Health in Q2 2016 and held it in 3 quarters.
Highbridge Capital Management's Phibro Animal Health position peaked at $252K in Q1 2017.
174 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.